BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 20441993)

  • 1. Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke.
    Yoo SH; Kwon SU; Lee DH; Kim SJ; Kim JS; Kang DW
    J Neurol Sci; 2010 Jul; 294(1-2):119-23. PubMed ID: 20441993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS.
    Hill MD; Rowley HA; Adler F; Eliasziw M; Furlan A; Higashida RT; Wechsler LR; Roberts HC; Dillon WP; Fischbein NJ; Firszt CM; Schulz GA; Buchan AM;
    Stroke; 2003 Aug; 34(8):1925-31. PubMed ID: 12843342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
    Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
    Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients.
    Schellinger PD; Thomalla G; Fiehler J; Köhrmann M; Molina CA; Neumann-Haefelin T; Ribo M; Singer OC; Zaro-Weber O; Sobesky J
    Stroke; 2007 Oct; 38(10):2640-5. PubMed ID: 17702961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH
    Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report.
    Cho AH; Sohn SI; Han MK; Lee DH; Kim JS; Choi CG; Sohn CH; Kwon SU; Suh DC; Kim SJ; Bae HJ; Kang DW
    Cerebrovasc Dis; 2008; 25(6):572-9. PubMed ID: 18483457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Primary Imaging Modality-Computed Tomography or Magnetic Resonance Imaging-Influence Stroke Physicians' Certainty on Whether or Not to Give Thrombolysis to Randomized Acute Stroke Patients?
    Hansen CK; Christensen A; Rodgers H; Havsteen I; Kruuse C; Christensen H
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):926-935. PubMed ID: 29198901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systemized stroke code significantly reduced time intervals for using intravenous tissue plasminogen activator under magnetic resonance imaging screening.
    Sohn SW; Park HS; Cha JK; Nah HW; Kim DH; Kang MJ; Choi JH; Huh JT
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):465-72. PubMed ID: 25524016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.
    Mattle HP; Arnold M; Georgiadis D; Baumann C; Nedeltchev K; Benninger D; Remonda L; von Büdingen C; Diana A; Pangalu A; Schroth G; Baumgartner RW
    Stroke; 2008 Feb; 39(2):379-83. PubMed ID: 18096842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.
    Earnshaw SR; McDade C; Chapman AM; Jackson D; Schwamm L
    Clin Ther; 2012 Jul; 34(7):1544-58. PubMed ID: 22695225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility determination for intravenous thrombolysis based on radiology interpretation report of the head CT scan in patients with acute ischemic stroke.
    Hassan AE; Majidi S; Janjua NA; Chaudhry SA; Tekle WG; Grigoryan M; Qureshi AI
    J Neuroimaging; 2014; 24(4):349-53. PubMed ID: 24015702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI screening before standard tissue plasminogen activator therapy is feasible and safe.
    Kang DW; Chalela JA; Dunn W; Warach S;
    Stroke; 2005 Sep; 36(9):1939-43. PubMed ID: 16081864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset.
    Ebinger M; Scheitz JF; Kufner A; Endres M; Fiebach JB; Nolte CH
    Eur J Neurol; 2012 Feb; 19(2):348-50. PubMed ID: 21895879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.